Theseus Pharmaceuticals Q2 EPS $(0.30) Up From $(6.82) YoY

Theseus Pharmaceuticals (NASDAQ:THRX) reported quarterly losses of $(0.30) per share. This is a 95.6 percent increase over losses of $(6.82) per share from the same period last year.